Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Barrett, T; Xie, T; Piao, Y; Dillon-Carter, O; Kargul, GJ; Lim, MK; Chrest, FJ; Wersto, R; Rowley, DL; Juhaszova, M; Zhou, L; Vawter, MP; Becker, KG; Cheadle, C; Wood, WH; McCann, UD; Freed, WJ; Ko, MS; Ricaurte, GA; Donovan, DM
   A murine dopamine neuron-specific cDNA library and microarray: Increased COXI expression during methamphetamine neurotoxicity
   NEUROBIOLOGY OF DISEASE
   
   T. Barrett et al., "A murine dopamine neuron-specific cDNA library and microarray: Increased COXI expression during methamphetamine neurotoxicity", NEUROBIOL D, 8(5), 2001, pp. 822-833
2. Laakso, A; Bergman, J; Haaparanta, M; Vilkman, H; Solin, O; Syvalahti, E; Hietala, J
   Decreased striatal dopamine transporter binding in vivo in chronic schizophrenia
   SCHIZOPHRENIA RESEARCH
   
   A. Laakso et al., "Decreased striatal dopamine transporter binding in vivo in chronic schizophrenia", SCHIZOPHR R, 52(1-2), 2001, pp. 115-120
3. Rinne, JO; Nurmi, E; Ruottinen, HM; Bergman, J; Eskola, O; Solin, O
   [F-18]FDOPA and [F-18]CFT are both sensitive PET markers to detect presynaptic dopaminergic hypofunction in early Parkinson's disease
   SYNAPSE
   
   J.O. Rinne et al., "[F-18]FDOPA and [F-18]CFT are both sensitive PET markers to detect presynaptic dopaminergic hypofunction in early Parkinson's disease", SYNAPSE, 40(3), 2001, pp. 193-200
4. Fischman, AJ; Bonab, AA; Babich, JW; Livni, E; Alpert, NM; Meltzer, PC; Madras, BK
   [C-11,I-127] altropane: A highly selective ligand for PET imaging of dopamine transporter sites
   SYNAPSE
   
   A.J. Fischman et al., "[C-11,I-127] altropane: A highly selective ligand for PET imaging of dopamine transporter sites", SYNAPSE, 39(4), 2001, pp. 332-342
5. Cho, AK; Melega, WP; Kuczenski, R; Segal, DS
   Relevance of pharmacokinetic parameters in animal models of methamphetamine abuse
   SYNAPSE
   
   A.K. Cho et al., "Relevance of pharmacokinetic parameters in animal models of methamphetamine abuse", SYNAPSE, 39(2), 2001, pp. 161-166
6. Letchworth, SR; Nader, MA; Smith, HR; Friedman, DP; Porrino, LJ
   Progression of changes in dopamine transporter binding site density as a result of cocaine self-administration in rhesus monkeys
   JOURNAL OF NEUROSCIENCE
   
   S.R. Letchworth et al., "Progression of changes in dopamine transporter binding site density as a result of cocaine self-administration in rhesus monkeys", J NEUROSC, 21(8), 2001, pp. 2799-2807
7. Deng, XL; Wang, Y; Chou, J; Cadet, JL
   Methamphetamine causes widespread apoptosis in the mouse brain: evidence from using an improved TUNEL histochemical method
   MOLECULAR BRAIN RESEARCH
   
   X.L. Deng et al., "Methamphetamine causes widespread apoptosis in the mouse brain: evidence from using an improved TUNEL histochemical method", MOL BRAIN R, 93(1), 2001, pp. 64-69
8. Corera, AT; Do-Rego, JC; Costentin, J; Bonnet, JJ
   Differential sensitivity to NaCl for inhibitors and substrates that recognize mutually exclusive binding sites on the neuronal transporter of dopamine in rat striatal membranes
   NEUROSCIENCE RESEARCH
   
   A.T. Corera et al., "Differential sensitivity to NaCl for inhibitors and substrates that recognize mutually exclusive binding sites on the neuronal transporter of dopamine in rat striatal membranes", NEUROSCI RE, 39(3), 2001, pp. 319-325
9. Yuan, J; Callahan, BT; McCann, UD; Ricaurte, GA
   Evidence against an essential role of endogenous brain dopamine in methamphetamine-induced dopaminergic neurotoxicity
   JOURNAL OF NEUROCHEMISTRY
   
   J. Yuan et al., "Evidence against an essential role of endogenous brain dopamine in methamphetamine-induced dopaminergic neurotoxicity", J NEUROCHEM, 77(5), 2001, pp. 1338-1347
10. Reith, MEA; Berfield, JL; Wang, LC; Ferrer, JV; Javitch, JA
    The uptake inhibitors cocaine and benztropine differentially alter the conformation of the human dopamine transporter
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    M.E.A. Reith et al., "The uptake inhibitors cocaine and benztropine differentially alter the conformation of the human dopamine transporter", J BIOL CHEM, 276(31), 2001, pp. 29012-29018
11. Sabol, KE; Roach, JT; Broom, SL; Ferreira, C; Preau, MM
    Long-term effects of a high-dose methamphetamine regimen on subsequent methamphetamine-induced dopamine release in vivo
    BRAIN RESEARCH
    
    K.E. Sabol et al., "Long-term effects of a high-dose methamphetamine regimen on subsequent methamphetamine-induced dopamine release in vivo", BRAIN RES, 892(1), 2001, pp. 122-129
12. Ouchi, Y; Kanno, T; Okada, H; Yoshikawa, E; Futatsubashi, M; Nobezawa, S; Torizuka, T; Tanaka, K
    Changes in dopamine availability in the nigrostriatal and mesocortical dopaminergic systems by gait in Parkinson's disease
    BRAIN
    
    Y. Ouchi et al., "Changes in dopamine availability in the nigrostriatal and mesocortical dopaminergic systems by gait in Parkinson's disease", BRAIN, 124, 2001, pp. 784-792
13. Sekine, Y; Iyo, M; Ouchi, Y; Matsunaga, T; Tsukada, H; Okada, H; Yoshikawa, E; Futatsubashi, M; Takei, N; Mori, N
    Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET
    AMERICAN JOURNAL OF PSYCHIATRY
    
    Y. Sekine et al., "Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET", AM J PSYCHI, 158(8), 2001, pp. 1206-1214
14. Volkow, ND; Chang, L; Wang, GJ; Fowler, JS; Leonido-Yee, M; Franceschi, D; Sedler, MJ; Gatley, SJ; Hitzemann, R; Ding, YS; Logan, J; Wong, C; Miller, EN
    Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers
    AMERICAN JOURNAL OF PSYCHIATRY
    
    N.D. Volkow et al., "Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers", AM J PSYCHI, 158(3), 2001, pp. 377-382
15. Isovich, E; Mijnster, MJ; Flugge, G; Fuchs, E
    Chronic psychosocial stress reduces the density of dopamine transporters
    EUROPEAN JOURNAL OF NEUROSCIENCE
    
    E. Isovich et al., "Chronic psychosocial stress reduces the density of dopamine transporters", EUR J NEURO, 12(3), 2000, pp. 1071-1078
16. McCann, UD; Ricaurte, GA
    Drug abuse and dependence: hazards and consequences of heroin, cocaine andamphetamines
    CURRENT OPINION IN PSYCHIATRY
    
    U.D. McCann e G.A. Ricaurte, "Drug abuse and dependence: hazards and consequences of heroin, cocaine andamphetamines", CUR OPIN P, 13(3), 2000, pp. 321-325
17. Bobes, J; McCann, UD
    Developments in the treatment of drug dependence
    CURRENT OPINION IN PSYCHIATRY
    
    J. Bobes e U.D. McCann, "Developments in the treatment of drug dependence", CUR OPIN P, 13(3), 2000, pp. 333-338
18. Melega, WP; Lacan, G; Desalles, AAF; Phelps, ME
    Long-term methamphetamine-induced decreases of [C-11]WIN 35,428 binding instriatum are reduced by GDNF: PET studies in the vervet monkey
    SYNAPSE
    
    W.P. Melega et al., "Long-term methamphetamine-induced decreases of [C-11]WIN 35,428 binding instriatum are reduced by GDNF: PET studies in the vervet monkey", SYNAPSE, 35(4), 2000, pp. 243-249
19. Nurmi, E; Ruottinen, HM; Kaasinen, V; Bergman, J; Haaparanta, M; Solin, O; Rinne, JO
    Progression in Parkinson's disease: A positron emission tomography study with a dopamine transporter ligand [F-18] CFT
    ANNALS OF NEUROLOGY
    
    E. Nurmi et al., "Progression in Parkinson's disease: A positron emission tomography study with a dopamine transporter ligand [F-18] CFT", ANN NEUROL, 47(6), 2000, pp. 804-808
20. Nurmi, E; Bergman, J; Eskola, O; Solin, O; Hinkka, SM; Sonninen, P; Rinne, JO
    Reproducibility and effect of levodopa on dopamine transporter function measurements: A [F-18]CFT PET study
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
    
    E. Nurmi et al., "Reproducibility and effect of levodopa on dopamine transporter function measurements: A [F-18]CFT PET study", J CEREBR B, 20(11), 2000, pp. 1604-1609
21. Xie, T; McCann, UD; Kim, S; Yuan, J; Ricaurte, GA
    Effect of temperature on dopamine transporter function and intracellular accumulation of methamphetamine: Implications for methamphetamine-induced dopaminergic neurotoxicity
    JOURNAL OF NEUROSCIENCE
    
    T. Xie et al., "Effect of temperature on dopamine transporter function and intracellular accumulation of methamphetamine: Implications for methamphetamine-induced dopaminergic neurotoxicity", J NEUROSC, 20(20), 2000, pp. 7838-7845
22. Kimmel, HL; Carroll, FI; Kuhar, MJ
    Dopamine transporter synthesis and degradation rate in rat striatum and nucleus accumbens using RTI-76
    NEUROPHARMACOLOGY
    
    H.L. Kimmel et al., "Dopamine transporter synthesis and degradation rate in rat striatum and nucleus accumbens using RTI-76", NEUROPHARM, 39(4), 2000, pp. 578-585
23. Corera, AT; Costentin, J; Bonnet, JJ
    Binding of uptake blockers to the neuronal dopamine transporter: further investigation about cationic and anionic requirements
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    
    A.T. Corera et al., "Binding of uptake blockers to the neuronal dopamine transporter: further investigation about cationic and anionic requirements", N-S ARCH PH, 362(3), 2000, pp. 213-221
24. Wang, LJC; Berfield, JL; Kuhar, MJ; Carroll, FI; Reith, MEA
    RTI-76, an isothiocyanate derivative of a phenyltropane cocaine analog, asa tool for irreversibly inactivating dopamine transporter function in vitro
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    
    L.J.C. Wang et al., "RTI-76, an isothiocyanate derivative of a phenyltropane cocaine analog, asa tool for irreversibly inactivating dopamine transporter function in vitro", N-S ARCH PH, 362(3), 2000, pp. 238-247
25. Ladenheim, B; Krasnova, IN; Deng, XL; Oyler, JM; Polettini, A; Moran, TH; Huestis, MA; Cadet, JL
    Methamphetamine-induced neurotoxicity is attenuated in transgenic mice with a null mutation for interleukin-6
    MOLECULAR PHARMACOLOGY
    
    B. Ladenheim et al., "Methamphetamine-induced neurotoxicity is attenuated in transgenic mice with a null mutation for interleukin-6", MOLEC PHARM, 58(6), 2000, pp. 1247-1256
26. Hogan, KA; Staal, RGW; Sonsalla, PK
    Analysis of VMAT2 binding after methamphetamine or MPTP treatment: Disparity between homogenates and vesicle preparations
    JOURNAL OF NEUROCHEMISTRY
    
    K.A. Hogan et al., "Analysis of VMAT2 binding after methamphetamine or MPTP treatment: Disparity between homogenates and vesicle preparations", J NEUROCHEM, 74(5), 2000, pp. 2217-2220
27. Li, LB; Reith, MEA
    Interaction of Na+, K+, and Cl- with the binding of amphetamine, octopamine, and tyramine to the human dopamine transporter
    JOURNAL OF NEUROCHEMISTRY
    
    L.B. Li e M.E.A. Reith, "Interaction of Na+, K+, and Cl- with the binding of amphetamine, octopamine, and tyramine to the human dopamine transporter", J NEUROCHEM, 74(4), 2000, pp. 1538-1552
28. Chen, NH; Ferrer, JV; Javitch, JA; Justice, JB
    Transport-dependent accessibility of a cytoplasmic loop cysteine in the human dopamine transporter
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    N.H. Chen et al., "Transport-dependent accessibility of a cytoplasmic loop cysteine in the human dopamine transporter", J BIOL CHEM, 275(3), 2000, pp. 1608-1614
29. Kim, GM; Kim, SE; Lee, WY
    Preclinical impairment of the striatal dopamine transporter system in sporadic olivopontocerebellar atrophy: Studied with [I-123]beta-CIT and SPECT
    EUROPEAN NEUROLOGY
    
    G.M. Kim et al., "Preclinical impairment of the striatal dopamine transporter system in sporadic olivopontocerebellar atrophy: Studied with [I-123]beta-CIT and SPECT", EUR NEUROL, 43(1), 2000, pp. 23-29
30. Harvey, DC; Lacan, G; Tanious, SP; Melega, WP
    Recovery from methamphetamine induced long-term nigrostriatal dopaminergicdeficits without substantia nigra cell loss
    BRAIN RESEARCH
    
    D.C. Harvey et al., "Recovery from methamphetamine induced long-term nigrostriatal dopaminergicdeficits without substantia nigra cell loss", BRAIN RES, 871(2), 2000, pp. 259-270
31. Schenk, S; Partridge, B; Shippenberg, TS
    Reinstatement of extinguished drug-taking behavior in rats: effect of the kappa-opioid receptor agonist, U69593
    PSYCHOPHARMACOLOGY
    
    S. Schenk et al., "Reinstatement of extinguished drug-taking behavior in rats: effect of the kappa-opioid receptor agonist, U69593", PSYCHOPHAR, 151(1), 2000, pp. 85-90
32. Katz, JL; Izenwasser, S; Terry, P
    Relationships among dopamine transporter affinities and cocaine-like discriminative-stimulus effects
    PSYCHOPHARMACOLOGY
    
    J.L. Katz et al., "Relationships among dopamine transporter affinities and cocaine-like discriminative-stimulus effects", PSYCHOPHAR, 148(1), 2000, pp. 90-98
33. Kuhlmann, AC; Guilarte, TR
    Regional and temporal expression of the peripheral benzodiazepine receptorin MPTP neurotoxicity
    TOXICOLOGICAL SCIENCES
    
    A.C. Kuhlmann e T.R. Guilarte, "Regional and temporal expression of the peripheral benzodiazepine receptorin MPTP neurotoxicity", TOXICOL SCI, 48(1), 1999, pp. 107-116
34. Cumming, P; Yokoi, F; Chen, AJ; Deep, P; Dagher, A; Reutens, D; Kapczinski, F; Wong, DF; Gjedde, A
    Pharmacokinetics of radiotracers in human plasma during positron emission tomography
    SYNAPSE
    
    P. Cumming et al., "Pharmacokinetics of radiotracers in human plasma during positron emission tomography", SYNAPSE, 34(2), 1999, pp. 124-134
35. Ouchi, Y; Yoshikawa, E; Okada, H; Futatsubashi, M; Sekine, Y; Iyo, M; Sakamoto, M
    Alterations in binding site density of dopamine transporter in the striatum, orbitofrontal cortex, and amygdala in early Parkinson's disease: Compartment analysis for beta-CFT binding with positron emission tomography
    ANNALS OF NEUROLOGY
    
    Y. Ouchi et al., "Alterations in binding site density of dopamine transporter in the striatum, orbitofrontal cortex, and amygdala in early Parkinson's disease: Compartment analysis for beta-CFT binding with positron emission tomography", ANN NEUROL, 45(5), 1999, pp. 601-610
36. Nobrega, JN; Gernert, M; Loscher, W; Raymond, R; Belej, T; Richter, A
    Tyrosine hydroxylase immunoreactivity and [H-3]win 35,428 binding to the dopamine transporter in a hamster model of idiopathic paroxysmal dystonia
    NEUROSCIENCE
    
    J.N. Nobrega et al., "Tyrosine hydroxylase immunoreactivity and [H-3]win 35,428 binding to the dopamine transporter in a hamster model of idiopathic paroxysmal dystonia", NEUROSCIENC, 92(1), 1999, pp. 211-217
37. Vaugeois, JM; Corera, AT; Deslandes, A; Costentin, J
    Although chemically related to amineptine, the antidepressant tianeptine is not a dopamine uptake inhibitor
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    
    J.M. Vaugeois et al., "Although chemically related to amineptine, the antidepressant tianeptine is not a dopamine uptake inhibitor", PHARM BIO B, 63(2), 1999, pp. 285-290
38. Ilgin, N; Zubieta, J; Reich, SG; Dannals, RF; Ravert, HT; Frost, JJ
    PET imaging of the dopamine transporter in progressive supranuclear palsy and Parkinson's disease
    NEUROLOGY
    
    N. Ilgin et al., "PET imaging of the dopamine transporter in progressive supranuclear palsy and Parkinson's disease", NEUROLOGY, 52(6), 1999, pp. 1221-1226
39. Rinne, JO; Ruottinen, H; Bergman, J; Haaparanta, M; Sonninen, P; Solin, O
    Usefulness of a dopamine transporter PET ligand [F-18]beta-CFT in assessing disability in Parkinson's disease
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
    
    J.O. Rinne et al., "Usefulness of a dopamine transporter PET ligand [F-18]beta-CFT in assessing disability in Parkinson's disease", J NE NE PSY, 67(6), 1999, pp. 737-741
40. Li, LB; Reith, MEA
    Modeling of the interaction of Na+ and K+ with the binding of dopamine and[H-3]WIN 35,428 to the human dopamine transporter
    JOURNAL OF NEUROCHEMISTRY
    
    L.B. Li e M.E.A. Reith, "Modeling of the interaction of Na+ and K+ with the binding of dopamine and[H-3]WIN 35,428 to the human dopamine transporter", J NEUROCHEM, 72(3), 1999, pp. 1095-1109
41. MATTES CE; BELENDIUK GW; LYNCH TJ; BRADY RO; DRETCHEN KL
    BUTYRYLCHOLINESTERASE - AN ENZYME ANTIDOTE FOR COCAINE INTOXICATION
    Addiction biology
    
    C.E. Mattes et al., "BUTYRYLCHOLINESTERASE - AN ENZYME ANTIDOTE FOR COCAINE INTOXICATION", Addiction biology, 3(2), 1998, pp. 171-188
42. MADRAS BK; MELTZER PC; LIANG AY; ELMALEH DR; BABICH J; FISCHMAN AJ
    ALTROPANE, A SPECT OR PET IMAGING PROBE FOR DOPAMINE NEURONS - I - DOPAMINE TRANSPORTER BINDING IN PRIMATE BRAIN
    Synapse
    
    B.K. Madras et al., "ALTROPANE, A SPECT OR PET IMAGING PROBE FOR DOPAMINE NEURONS - I - DOPAMINE TRANSPORTER BINDING IN PRIMATE BRAIN", Synapse, 29(2), 1998, pp. 93-104
43. MADRAS BK; GRACZ LM; MELTZER PC; LIANG AY; ELMALEH DR; KAUFMAN MJ; FISCHMAN AJ
    ALTROPANE, A SPECT OR PET IMAGING PROBE FOR DOPAMINE NEURONS - II - DISTRIBUTION TO DOPAMINE-RICH REGIONS OF PRIMATE BRAIN
    Synapse
    
    B.K. Madras et al., "ALTROPANE, A SPECT OR PET IMAGING PROBE FOR DOPAMINE NEURONS - II - DISTRIBUTION TO DOPAMINE-RICH REGIONS OF PRIMATE BRAIN", Synapse, 29(2), 1998, pp. 105-115
44. MADRAS BK; GRACZ LM; FAHEY MA; ELMALEH D; MELTZER PC; LIANG AY; STOPA EG; BABICH J; FISCHMAN AJ
    ALTROPANE, A SPECT OR PET IMAGING PROBE FOR DOPAMINE NEURONS - III - HUMAN DOPAMINE TRANSPORTER IN POSTMORTEM NORMAL AND PARKINSONS DISEASED BRAIN
    Synapse
    
    B.K. Madras et al., "ALTROPANE, A SPECT OR PET IMAGING PROBE FOR DOPAMINE NEURONS - III - HUMAN DOPAMINE TRANSPORTER IN POSTMORTEM NORMAL AND PARKINSONS DISEASED BRAIN", Synapse, 29(2), 1998, pp. 116-127
45. FISCHMAN AJ; BONAB AA; BABICH JW; PALMER EP; ALPERT NM; ELMALEH DR; CALLAHAN RJ; BARROW SA; GRAHAM W; MELTZER PC; HANSON RN; MADRAS BK
    RAPID DETECTION OF PARKINSONS-DISEASE BY SPECT WITH ALTROPANE - A SELECTIVE LIGAND FOR DOPAMINE TRANSPORTERS
    Synapse
    
    A.J. Fischman et al., "RAPID DETECTION OF PARKINSONS-DISEASE BY SPECT WITH ALTROPANE - A SELECTIVE LIGAND FOR DOPAMINE TRANSPORTERS", Synapse, 29(2), 1998, pp. 128-141
46. LAAKSO A; BERGMAN J; HAAPARANTA M; VILKMAN H; SOLIN O; HIETALA J
    [F-18] CFT ([F-18]WIN-35,428), A RADIOLIGAND TO STUDY THE DOPAMINE TRANSPORTER WITH PET - CHARACTERIZATION IN HUMAN-SUBJECTS
    Synapse
    
    A. Laakso et al., "[F-18] CFT ([F-18]WIN-35,428), A RADIOLIGAND TO STUDY THE DOPAMINE TRANSPORTER WITH PET - CHARACTERIZATION IN HUMAN-SUBJECTS", Synapse, 28(3), 1998, pp. 244-250
47. BROWNELL AL; LIVNI E; GALPERN W; ISACSON O
    IN-VIVO PET IMAGING IN RAT OF DOPAMINE TERMINALS REVEALS FUNCTIONAL NEURAL TRANSPLANTS
    Annals of neurology
    
    A.L. Brownell et al., "IN-VIVO PET IMAGING IN RAT OF DOPAMINE TERMINALS REVEALS FUNCTIONAL NEURAL TRANSPLANTS", Annals of neurology, 43(3), 1998, pp. 387-390
48. Melega, WP; Lacan, G; Harvey, DC; Huang, SC; Phelps, ME
    Dizocilpine and reduced body temperature do not prevent methamphetamine-induced neurotoxicity in the vervet monkey: [C-11]WIN 35,428 positron emission tomography studies
    NEUROSCIENCE LETTERS
    
    W.P. Melega et al., "Dizocilpine and reduced body temperature do not prevent methamphetamine-induced neurotoxicity in the vervet monkey: [C-11]WIN 35,428 positron emission tomography studies", NEUROSCI L, 258(1), 1998, pp. 17-20
49. MCCANN UD; WONG DF; YOKOI F; VILLEMAGNE V; DANNALS RF; RICAURTE GA
    REDUCED STRIATAL DOPAMINE TRANSPORTER DENSITY IN ABSTINENT METHAMPHETAMINE AND METHCATHINONE USERS - EVIDENCE FROM POSITRON-EMISSION-TOMOGRAPHY STUDIES WITH [C-11] WIN-35,428
    The Journal of neuroscience
    
    U.D. Mccann et al., "REDUCED STRIATAL DOPAMINE TRANSPORTER DENSITY IN ABSTINENT METHAMPHETAMINE AND METHCATHINONE USERS - EVIDENCE FROM POSITRON-EMISSION-TOMOGRAPHY STUDIES WITH [C-11] WIN-35,428", The Journal of neuroscience, 18(20), 1998, pp. 8417-8422
50. VILLEMAGNE V; YUAN J; WONG DF; DANNALS RF; HATZIDIMITRIOU G; MATHEWS WB; RAVERT HT; MUSACHIO J; MCCANN UD; RICAURTE GA
    BRAIN DOPAMINE NEUROTOXICITY IN BABOONS TREATED WITH DOSES OF METHAMPHETAMINE COMPARABLE TO THOSE RECREATIONALLY ABUSED BY HUMANS - EVIDENCE FROM [C-11] WIN-35,428 POSITRON-EMISSION-TOMOGRAPHY STUDIES AND DIRECT IN-VITRO DETERMINATIONS
    The Journal of neuroscience
    
    V. Villemagne et al., "BRAIN DOPAMINE NEUROTOXICITY IN BABOONS TREATED WITH DOSES OF METHAMPHETAMINE COMPARABLE TO THOSE RECREATIONALLY ABUSED BY HUMANS - EVIDENCE FROM [C-11] WIN-35,428 POSITRON-EMISSION-TOMOGRAPHY STUDIES AND DIRECT IN-VITRO DETERMINATIONS", The Journal of neuroscience, 18(1), 1998, pp. 419-427
51. ZHANG L; ELMER LW; LITTLE KY
    EXPRESSION AND REGULATION OF THE HUMAN DOPAMINE TRANSPORTER IN A NEURONAL CELL-LINE
    Molecular brain research
    
    L. Zhang et al., "EXPRESSION AND REGULATION OF THE HUMAN DOPAMINE TRANSPORTER IN A NEURONAL CELL-LINE", Molecular brain research, 59(1), 1998, pp. 66-73
52. MALISON RT; MCCANCE E; CARPENTER LL; BALDWIN RM; SEIBYL JP; PRICE LH; KOSTEN TR; INNIS RB
    [I-123] BETA-CIT SPECT IMAGING OF DOPAMINE TRANSPORTER AVAILABILITY AFTER MAZINDOL ADMINISTRATION IN HUMAN COCAINE ADDICTS
    Psychopharmacology
    
    R.T. Malison et al., "[I-123] BETA-CIT SPECT IMAGING OF DOPAMINE TRANSPORTER AVAILABILITY AFTER MAZINDOL ADMINISTRATION IN HUMAN COCAINE ADDICTS", Psychopharmacology, 137(4), 1998, pp. 321-325
53. MILLER GW; STALEY JK; HEILMAN CJ; PEREZ JT; MASH DC; RYE DB; LEVEY AI
    IMMUNOCHEMICAL ANALYSIS OF DOPAMINE TRANSPORTER PROTEIN IN PARKINSONS-DISEASE
    Annals of neurology
    
    G.W. Miller et al., "IMMUNOCHEMICAL ANALYSIS OF DOPAMINE TRANSPORTER PROTEIN IN PARKINSONS-DISEASE", Annals of neurology, 41(4), 1997, pp. 530-539
54. ALLARD P; NORLEN M
    UNCHANGED DENSITY OF CAUDATE-NUCLEUS DOPAMINE UPTAKE SITES IN DEPRESSED SUICIDE VICTIMS
    Journal of neural transmission
    
    P. Allard e M. Norlen, "UNCHANGED DENSITY OF CAUDATE-NUCLEUS DOPAMINE UPTAKE SITES IN DEPRESSED SUICIDE VICTIMS", Journal of neural transmission, 104(11-12), 1997, pp. 1353-1360
55. COULTER CL; HAPPE HK; MURRIN LC
    DOPAMINE TRANSPORTER DEVELOPMENT IN POSTNATAL RAT STRIATUM, AN AUTORADIOGRAPHIC STUDY WITH [H-3]WIN 35,428
    Developmental brain research
    
    C.L. Coulter et al., "DOPAMINE TRANSPORTER DEVELOPMENT IN POSTNATAL RAT STRIATUM, AN AUTORADIOGRAPHIC STUDY WITH [H-3]WIN 35,428", Developmental brain research, 104(1-2), 1997, pp. 55-62
56. HUME SP; BROWN DJ; ASHWORTH S; HIRANI E; LUTHRA SK; LAMMERTSMA AA
    IN-VIVO SATURATION KINETICS OF 2 DOPAMINE TRANSPORTER PROBES MEASUREDUSING A SMALL ANIMAL POSITRON-EMISSION-TOMOGRAPHY SCANNER
    Journal of neuroscience methods
    
    S.P. Hume et al., "IN-VIVO SATURATION KINETICS OF 2 DOPAMINE TRANSPORTER PROBES MEASUREDUSING A SMALL ANIMAL POSITRON-EMISSION-TOMOGRAPHY SCANNER", Journal of neuroscience methods, 76(1), 1997, pp. 45-51
57. CHEN NH; DING JH; WANG YL; REITH MEA
    POTENTIAL MISCONCEPTIONS IN DOPAMINE TRANSPORTER ASSAYS ARISING FROM THE BINDING OF [I-125] RTI-121 TO FILTERS - EFFECT OF IONS AND COCAINE
    Journal of neuroscience methods
    
    N.H. Chen et al., "POTENTIAL MISCONCEPTIONS IN DOPAMINE TRANSPORTER ASSAYS ARISING FROM THE BINDING OF [I-125] RTI-121 TO FILTERS - EFFECT OF IONS AND COCAINE", Journal of neuroscience methods, 75(2), 1997, pp. 179-186
58. XU C; COFFEY LL; REITH MEA
    BINDING DOMAINS FOR BLOCKERS AND SUBSTRATES ON THE DOPAMINE TRANSPORTER IN RAT STRIATAL MEMBRANES STUDIED BY PROTECTION AGAINST N-ETHYLMALEIMIDE-INDUCED REDUCTION OF [H-3]WIN-35,428 BINDING
    Naunyn-Schmiedeberg's archives of pharmacology
    
    C. Xu et al., "BINDING DOMAINS FOR BLOCKERS AND SUBSTRATES ON THE DOPAMINE TRANSPORTER IN RAT STRIATAL MEMBRANES STUDIED BY PROTECTION AGAINST N-ETHYLMALEIMIDE-INDUCED REDUCTION OF [H-3]WIN-35,428 BINDING", Naunyn-Schmiedeberg's archives of pharmacology, 355(1), 1997, pp. 64-73
59. LI HK; GEORGE VK; CROSSLAND WJ; ANDERSON GF; DHABUWALA CB
    CHARACTERIZATION OF COCAINE BINDING-SITES IN THE RAT TESTES
    The Journal of urology
    
    H.K. Li et al., "CHARACTERIZATION OF COCAINE BINDING-SITES IN THE RAT TESTES", The Journal of urology, 158(3), 1997, pp. 962-965
60. WU Q; COFFEY LL; REITH MEA
    CATIONS AFFECT [H-3] MAZINDOL AND [H-3] WIN-35,428 BINDING TO THE HUMAN DOPAMINE TRANSPORTER IN A SIMILAR FASHION
    Journal of neurochemistry
    
    Q. Wu et al., "CATIONS AFFECT [H-3] MAZINDOL AND [H-3] WIN-35,428 BINDING TO THE HUMAN DOPAMINE TRANSPORTER IN A SIMILAR FASHION", Journal of neurochemistry, 69(3), 1997, pp. 1106-1118
61. FREY K; KILBOURN M; ROBINSON T
    REDUCED STRIATAL VESICULAR MONOAMINE TRANSPORTERS AFTER NEUROTOXIC BUT NOT AFTER BEHAVIORALLY-SENSITIZING DOSES OF METHAMPHETAMINE
    European journal of pharmacology
    
    K. Frey et al., "REDUCED STRIATAL VESICULAR MONOAMINE TRANSPORTERS AFTER NEUROTOXIC BUT NOT AFTER BEHAVIORALLY-SENSITIZING DOSES OF METHAMPHETAMINE", European journal of pharmacology, 334(2-3), 1997, pp. 273-279
62. REITH MEA; XU C; CHEN NH
    PHARMACOLOGY AND REGULATION OF THE NEURONAL DOPAMINE TRANSPORTER
    European journal of pharmacology
    
    M.E.A. Reith et al., "PHARMACOLOGY AND REGULATION OF THE NEURONAL DOPAMINE TRANSPORTER", European journal of pharmacology, 324(1), 1997, pp. 1-10
63. ZHANG L; COFFEY LL; REITH MEA
    REGULATION OF THE FUNCTIONAL-ACTIVITY OF THE HUMAN DOPAMINE TRANSPORTER BY PROTEIN-KINASE-C
    Biochemical pharmacology
    
    L. Zhang et al., "REGULATION OF THE FUNCTIONAL-ACTIVITY OF THE HUMAN DOPAMINE TRANSPORTER BY PROTEIN-KINASE-C", Biochemical pharmacology, 53(5), 1997, pp. 677-688
64. WILSON AA; DASILVA JN; HOULE S
    IN-VIVO EVALUATION OF [C-11] AND [F-18] LABELLED COCAINE ANALOGUES ASPOTENTIAL DOPAMINE TRANSPORTER LIGANDS FOR POSITRON EMISSION TOMOGRAPHY
    Nuclear medicine and biology
    
    A.A. Wilson et al., "IN-VIVO EVALUATION OF [C-11] AND [F-18] LABELLED COCAINE ANALOGUES ASPOTENTIAL DOPAMINE TRANSPORTER LIGANDS FOR POSITRON EMISSION TOMOGRAPHY", Nuclear medicine and biology, 23(2), 1996, pp. 141-146
65. HITRI A; LITTLE KY; ELLINWOOD EH
    EFFECT OF COCAINE ON DOPAMINE TRANSPORTER RECEPTORS DEPENDS ON ROUTESOF CHRONIC COCAINE ADMINISTRATION
    Neuropsychopharmacology
    
    A. Hitri et al., "EFFECT OF COCAINE ON DOPAMINE TRANSPORTER RECEPTORS DEPENDS ON ROUTESOF CHRONIC COCAINE ADMINISTRATION", Neuropsychopharmacology, 14(3), 1996, pp. 205-210
66. MORRIS ED; BABICH JW; ALPERT NM; BONAB AA; LIVNI E; WEISE S; HSU HB; CHRISTIAN BT; MADRAS BK; FISCHMAN AJ
    QUANTIFICATION OF DOPAMINE TRANSPORTER DENSITY IN MONKEYS BY DYNAMIC PET IMAGING OF MULTIPLE INJECTIONS OF C-11 CFT
    Synapse
    
    E.D. Morris et al., "QUANTIFICATION OF DOPAMINE TRANSPORTER DENSITY IN MONKEYS BY DYNAMIC PET IMAGING OF MULTIPLE INJECTIONS OF C-11 CFT", Synapse, 24(3), 1996, pp. 262-272
67. HAAPARANTA M; BERGMAN J; LAAKSO A; HIETALA J; SOLIN O
    [F-18]CFT ([F-18]WIN-35,428), A RADIOLIGAND TO STUDY THE DOPAMINE TRANSPORTER WITH PET - BIODISTRIBUTION IN RATS
    Synapse
    
    M. Haaparanta et al., "[F-18]CFT ([F-18]WIN-35,428), A RADIOLIGAND TO STUDY THE DOPAMINE TRANSPORTER WITH PET - BIODISTRIBUTION IN RATS", Synapse, 23(4), 1996, pp. 321-327
68. MADRAS BK; JONES AG; MAHMOOD A; ZIMMERMAN RE; GARADA B; HOLMAN BL; DAVISON A; BLUNDELL P; MELTZER PC
    TECHNEPINE - A HIGH-AFFINITY (99M)TECHNETIUM PROBE TO LABEL THE DOPAMINE TRANSPORTER IN BRAIN BY SPECT IMAGING
    Synapse
    
    B.K. Madras et al., "TECHNEPINE - A HIGH-AFFINITY (99M)TECHNETIUM PROBE TO LABEL THE DOPAMINE TRANSPORTER IN BRAIN BY SPECT IMAGING", Synapse, 22(3), 1996, pp. 239-246
69. KOUTSILIERI E; KORNHUBER J; DEGEN HJ; LESCH KP; SOPPER S; TERMEULEN V; RIEDERER P
    U-373 MG GLIOBLASTOMA AND IMR-32 NEUROBLASTOMA CELL-LINES EXPRESS THEDOPAMINE AND VESICULAR MONOAMINE TRANSPORTERS
    Journal of neuroscience research
    
    E. Koutsilieri et al., "U-373 MG GLIOBLASTOMA AND IMR-32 NEUROBLASTOMA CELL-LINES EXPRESS THEDOPAMINE AND VESICULAR MONOAMINE TRANSPORTERS", Journal of neuroscience research, 45(3), 1996, pp. 269-275
70. MOODY CA; GRANNEMAN JG; BANNON MJ
    DOPAMINE TRANSPORTER BINDING IN RAT STRIATUM AND NUCLEUS-ACCUMBENS ISUNALTERED FOLLOWING CHRONIC CHANGES IN DOPAMINE LEVELS
    Neuroscience letters
    
    C.A. Moody et al., "DOPAMINE TRANSPORTER BINDING IN RAT STRIATUM AND NUCLEUS-ACCUMBENS ISUNALTERED FOLLOWING CHRONIC CHANGES IN DOPAMINE LEVELS", Neuroscience letters, 217(1), 1996, pp. 55-57
71. MULLER L; HALLDIN C; LUNDKVIST C; SWAHN CG; FOGED C; HALL H; KARLSSON P; GINOVART N; NAKASHIMA Y; SUHARA T; FARDE L
    DEVELOPMENT OF RADIOLIGANDS FOR THE DOPAMINE TRANSPORTER
    Journal of radioanalytical and nuclear chemistry
    
    L. Muller et al., "DEVELOPMENT OF RADIOLIGANDS FOR THE DOPAMINE TRANSPORTER", Journal of radioanalytical and nuclear chemistry, 206(1), 1996, pp. 133-144
72. BROWNELL AL; ELMALEH DR; MELTZER PC; SHOUP TM; BROWNELL GL; FISCHMAN AJ; MADRAS BK
    COCAINE CONGENERS AS PET IMAGING PROBES FOR DOPAMINE TERMINALS
    The Journal of nuclear medicine
    
    A.L. Brownell et al., "COCAINE CONGENERS AS PET IMAGING PROBES FOR DOPAMINE TERMINALS", The Journal of nuclear medicine, 37(7), 1996, pp. 1186-1192
73. WILSON JM; LEVEY AI; RAJPUT A; ANG L; GUTTMAN M; SHANNAK K; NIZNIK HB; HORNYKIEWICZ O; PIFL C; KISH SJ
    DIFFERENTIAL CHANGES IN NEUROCHEMICAL MARKERS OF STRIATAL DOPAMINE NERVE-TERMINALS IN IDIOPATHIC PARKINSONS-DISEASE
    Neurology
    
    J.M. Wilson et al., "DIFFERENTIAL CHANGES IN NEUROCHEMICAL MARKERS OF STRIATAL DOPAMINE NERVE-TERMINALS IN IDIOPATHIC PARKINSONS-DISEASE", Neurology, 47(3), 1996, pp. 718-726
74. REITH MEA; XU C; ZHANG LA; COFFEY LL
    TRANSLOCATION OF DOPAMINE AND BINDING OF WIN-35,428 MEASURED UNDER IDENTICAL CONDITIONS IN CELLS EXPRESSING THE CLONED HUMAN DOPAMINE TRANSPORTER
    Naunyn-Schmiedeberg's archives of pharmacology
    
    M.E.A. Reith et al., "TRANSLOCATION OF DOPAMINE AND BINDING OF WIN-35,428 MEASURED UNDER IDENTICAL CONDITIONS IN CELLS EXPRESSING THE CLONED HUMAN DOPAMINE TRANSPORTER", Naunyn-Schmiedeberg's archives of pharmacology, 354(3), 1996, pp. 295-304
75. WONG DF; HARRIS JC; NAIDU S; YOKOI F; MARENCO S; DANNALS RF; RAVERT HT; YASTER M; EVANS A; ROUSSET O; BRYAN RN; GJEDDE A; KUHAR MJ; BREESE GR
    DOPAMINE TRANSPORTERS ARE MARKEDLY REDUCED IN LESCH-NYHAN DISEASE IN-VIVO
    Proceedings of the National Academy of Sciences of the United Statesof America
    
    D.F. Wong et al., "DOPAMINE TRANSPORTERS ARE MARKEDLY REDUCED IN LESCH-NYHAN DISEASE IN-VIVO", Proceedings of the National Academy of Sciences of the United Statesof America, 93(11), 1996, pp. 5539-5543
76. LEE FJS; PRISTUPA ZB; CILIAX BJ; LEVEY AI; NIZNIK HB
    THE DOPAMINE TRANSPORTER CARBOXYL-TERMINAL TAIL - TRUNCATIONS SUBSTITUTION MUTANTS SELECTIVELY CONFER HIGH-AFFINITY DOPAMINE UPTAKE WHILE ATTENUATING RECOGNITION OF THE LIGAND-BINDING DOMAIN/
    The Journal of biological chemistry
    
    F.J.S. Lee et al., "THE DOPAMINE TRANSPORTER CARBOXYL-TERMINAL TAIL - TRUNCATIONS SUBSTITUTION MUTANTS SELECTIVELY CONFER HIGH-AFFINITY DOPAMINE UPTAKE WHILE ATTENUATING RECOGNITION OF THE LIGAND-BINDING DOMAIN/", The Journal of biological chemistry, 271(34), 1996, pp. 20885-20894
77. ZHANG L; REITH MEA
    REGULATION OF THE FUNCTIONAL-ACTIVITY OF THE HUMAN DOPAMINE TRANSPORTER BY THE ARACHIDONIC-ACID PATHWAY
    European journal of pharmacology
    
    L. Zhang e M.E.A. Reith, "REGULATION OF THE FUNCTIONAL-ACTIVITY OF THE HUMAN DOPAMINE TRANSPORTER BY THE ARACHIDONIC-ACID PATHWAY", European journal of pharmacology, 315(3), 1996, pp. 345-354
78. ALLARD P; MARCUSSON JO; ROSS SB
    [H-3] WIN 35,428 BINDING IN THE HUMAN BRAIN
    Brain research
    
    P. Allard et al., "[H-3] WIN 35,428 BINDING IN THE HUMAN BRAIN", Brain research, 706(2), 1996, pp. 347-350
79. REITH MEA; XU C; COFFEY LL
    BINDING DOMAINS FOR BLOCKERS AND SUBSTRATES ON THE CLONED HUMAN DOPAMINE TRANSPORTER STUDIED BY PROTECTION AGAINST N-ETHYLMALEIMIDE-INDUCEDREDUCTION OF A-CARBOMETHOXY-3-BETA-(4-FLUOROPHENYL)[H-3]TROPANE ([H-3]WIN-35,428) BINDING
    Biochemical pharmacology
    
    M.E.A. Reith et al., "BINDING DOMAINS FOR BLOCKERS AND SUBSTRATES ON THE CLONED HUMAN DOPAMINE TRANSPORTER STUDIED BY PROTECTION AGAINST N-ETHYLMALEIMIDE-INDUCEDREDUCTION OF A-CARBOMETHOXY-3-BETA-(4-FLUOROPHENYL)[H-3]TROPANE ([H-3]WIN-35,428) BINDING", Biochemical pharmacology, 52(9), 1996, pp. 1435-1446
80. CHEN NH; XU C; COFFEY LL; REITH MEA
    -BETA-CARBOMETHOXY-3-BETA-(4-FLUOROPHENYL)TROPANE] BINDING TO RAT-BRAIN MEMBRANES - COMPARING DOPAMINE CELL BODY AREAS WITH NERVE-TERMINAL REGIONS
    Biochemical pharmacology
    
    N.H. Chen et al., "-BETA-CARBOMETHOXY-3-BETA-(4-FLUOROPHENYL)TROPANE] BINDING TO RAT-BRAIN MEMBRANES - COMPARING DOPAMINE CELL BODY AREAS WITH NERVE-TERMINAL REGIONS", Biochemical pharmacology, 51(4), 1996, pp. 563-566
81. DESAINTHILAIRE Z; PYTHON A; BLANC G; CHARNAY Y; GAILLARD JM
    EFFECTS OF WIN-35,428 A POTENT ANTAGONIST OF DOPAMINE TRANSPORTER ON SLEEP AND LOCOMOTOR-ACTIVITY IN RATS
    NeuroReport
    
    Z. Desainthilaire et al., "EFFECTS OF WIN-35,428 A POTENT ANTAGONIST OF DOPAMINE TRANSPORTER ON SLEEP AND LOCOMOTOR-ACTIVITY IN RATS", NeuroReport, 6(16), 1995, pp. 2182-2186
82. VALCHAR M; HANBAUER I
    RAT MESENCEPHALIC NEURONAL CELLS CULTURED FOR DIFFERENT PERIODS AS A MODEL OF DOPAMINE TRANSPORTER ONTOGENY
    Molecular neurobiology
    
    M. Valchar e I. Hanbauer, "RAT MESENCEPHALIC NEURONAL CELLS CULTURED FOR DIFFERENT PERIODS AS A MODEL OF DOPAMINE TRANSPORTER ONTOGENY", Molecular neurobiology, 11(1-3), 1995, pp. 111-119
83. LAIHINEN AO; RINNE JO; NAGREN KA; LEHIKOINEN PK; OIKONEN VJ; RUOTSALAINEN UH; RUOTTINEN HM; RINNE UK
    PET STUDIES ON BRAIN MONOAMINE TRANSPORTERS WITH CARBON-11-BETA-CIT IN PARKINSONS-DISEASE
    The Journal of nuclear medicine
    
    A.O. Laihinen et al., "PET STUDIES ON BRAIN MONOAMINE TRANSPORTERS WITH CARBON-11-BETA-CIT IN PARKINSONS-DISEASE", The Journal of nuclear medicine, 36(7), 1995, pp. 1263-1267
84. ALOYO VJ; PAZDALSKI PS; KIRIFIDES AL; HARVEY JA
    BEHAVIORAL SENSITIZATION, BEHAVIORAL TOLERANCE, AND INCREASED [H-3]WIN-35,428 BINDING IN RABBIT CAUDATE-NUCLEUS AFTER REPEATED INJECTIONS OF COCAINE
    Pharmacology, biochemistry and behavior
    
    V.J. Aloyo et al., "BEHAVIORAL SENSITIZATION, BEHAVIORAL TOLERANCE, AND INCREASED [H-3]WIN-35,428 BINDING IN RABBIT CAUDATE-NUCLEUS AFTER REPEATED INJECTIONS OF COCAINE", Pharmacology, biochemistry and behavior, 52(2), 1995, pp. 335-340
85. ROBINSON SE; MAHER JR; MCDOWELL KP; KUNKO PM
    EFFECTS OF COCAINE AND THE COCAINE ANALOG CFT ON GLUTAMATERGIC NEURONS
    Pharmacology, biochemistry and behavior
    
    S.E. Robinson et al., "EFFECTS OF COCAINE AND THE COCAINE ANALOG CFT ON GLUTAMATERGIC NEURONS", Pharmacology, biochemistry and behavior, 50(4), 1995, pp. 627-633
86. TOLLIVER BK; CARNEY JM
    LOCOMOTOR STIMULANT EFFECTS OF COCAINE AND NOVEL COCAINE ANALOGS IN DBA 2J AND C57BL/6J INBRED MICE/
    Pharmacology, biochemistry and behavior
    
    B.K. Tolliver e J.M. Carney, "LOCOMOTOR STIMULANT EFFECTS OF COCAINE AND NOVEL COCAINE ANALOGS IN DBA 2J AND C57BL/6J INBRED MICE/", Pharmacology, biochemistry and behavior, 50(2), 1995, pp. 163-169
87. GRACZ LM; MADRAS BK
    [H-3] WIN-35,428 ([H-3]CFT) BINDS TO MULTIPLE CHARGE-STATES OF THE SOLUBILIZED DOPAMINE TRANSPORTER IN PRIMATE STRIATUM
    The Journal of pharmacology and experimental therapeutics
    
    L.M. Gracz e B.K. Madras, "[H-3] WIN-35,428 ([H-3]CFT) BINDS TO MULTIPLE CHARGE-STATES OF THE SOLUBILIZED DOPAMINE TRANSPORTER IN PRIMATE STRIATUM", The Journal of pharmacology and experimental therapeutics, 273(3), 1995, pp. 1224-1234
88. GATLEY SJ; DING YS; VOLKOW ND; CHEN RY; SUGANO Y; FOWLER JS
    BINDING OF D-THREO-[C-11]METHYLPHENIDATE TO THE DOPAMINE TRANSPORTER IN-VIVO - INSENSITIVITY TO SYNAPTIC DOPAMINE
    European journal of pharmacology
    
    S.J. Gatley et al., "BINDING OF D-THREO-[C-11]METHYLPHENIDATE TO THE DOPAMINE TRANSPORTER IN-VIVO - INSENSITIVITY TO SYNAPTIC DOPAMINE", European journal of pharmacology, 281(2), 1995, pp. 141-149
89. COULTER CL; HAPPE HK; BERGMAN DA; MURRIN LC
    LOCALIZATION AND QUANTIFICATION OF THE DOPAMINE TRANSPORTER - COMPARISON OF [H-3]WIN-35,428 AND [I-125]RTI-55
    Brain research
    
    C.L. Coulter et al., "LOCALIZATION AND QUANTIFICATION OF THE DOPAMINE TRANSPORTER - COMPARISON OF [H-3]WIN-35,428 AND [I-125]RTI-55", Brain research, 690(2), 1995, pp. 217-224
90. XU C; COFFEY LL; REITH MEA
    TRANSLOCATION OF DOPAMINE AND BINDING OF 2 BETA-CARBOMETHOXY-3 BETA-(4-FLUOROPHENYL) TROPANE (WIN-35,428) MEASURED UNDER IDENTICAL CONDITIONS IN RAT STRIATAL SYNAPTOSOMAL PREPARATIONS - INHIBITION BY VARIOUS BLOCKERS
    Biochemical pharmacology
    
    C. Xu et al., "TRANSLOCATION OF DOPAMINE AND BINDING OF 2 BETA-CARBOMETHOXY-3 BETA-(4-FLUOROPHENYL) TROPANE (WIN-35,428) MEASURED UNDER IDENTICAL CONDITIONS IN RAT STRIATAL SYNAPTOSOMAL PREPARATIONS - INHIBITION BY VARIOUS BLOCKERS", Biochemical pharmacology, 49(3), 1995, pp. 339-350
91. STATHIS M; SCHEFFEL U; LEVER SZ; BOJA JW; CARROLL FI; KUHAR MJ
    RATE OF BINDING OF VARIOUS INHIBITORS AT THE DOPAMINE TRANSPORTER IN-VIVO
    Psychopharmacology
    
    M. Stathis et al., "RATE OF BINDING OF VARIOUS INHIBITORS AT THE DOPAMINE TRANSPORTER IN-VIVO", Psychopharmacology, 119(4), 1995, pp. 376-384
92. MADRAS BK; REITH MEA; MELTZER PC; DUTTA AK
    O-526, A PIPERIDINE ANALOG OF GBR-12909, RETAINS HIGH-AFFINITY FOR THE DOPAMINE TRANSPORTER IN MONKEY CAUDATE-PUTAMEN
    European journal of pharmacology. Molecular pharmacology section
    
    B.K. Madras et al., "O-526, A PIPERIDINE ANALOG OF GBR-12909, RETAINS HIGH-AFFINITY FOR THE DOPAMINE TRANSPORTER IN MONKEY CAUDATE-PUTAMEN", European journal of pharmacology. Molecular pharmacology section, 267(2), 1994, pp. 167-173
93. MADRAS BK; KAUFMAN MJ
    COCAINE ACCUMULATES IN DOPAMINE-RICH REGIONS OF PRIMATE BRAIN AFTER IV ADMINISTRATION - COMPARISON WITH MAZINDOL DISTRIBUTION
    Synapse
    
    B.K. Madras e M.J. Kaufman, "COCAINE ACCUMULATES IN DOPAMINE-RICH REGIONS OF PRIMATE BRAIN AFTER IV ADMINISTRATION - COMPARISON WITH MAZINDOL DISTRIBUTION", Synapse, 18(3), 1994, pp. 261-275
94. WILSON AA; DASILVA JN; HOULE S
    FACILE RADIOLABELING AND PURIFICATION OF TA-[O-(CH3)-C-11]-CARBOMETHOXY-3-BETA-ARYLTROPANES - RADIOTRACERS FOR THE DOPAMINE TRANSPORTER
    Journal of labelled compounds & radiopharmaceuticals
    
    A.A. Wilson et al., "FACILE RADIOLABELING AND PURIFICATION OF TA-[O-(CH3)-C-11]-CARBOMETHOXY-3-BETA-ARYLTROPANES - RADIOTRACERS FOR THE DOPAMINE TRANSPORTER", Journal of labelled compounds & radiopharmaceuticals, 34(8), 1994, pp. 759-765
95. DING YS; SUGANO Y; FOWLER JS; SALATA C
    SYNTHESIS OF THE RACEMATE AND INDIVIDUAL ENANTIOMERS OF [C-11] METHYLPHENIDATE FOR STUDYING PRESYNAPTIC DOPAMINERGIC NEURON WITH POSITRON EMISSION TOMOGRAPHY
    Journal of labelled compounds & radiopharmaceuticals
    
    Y.S. Ding et al., "SYNTHESIS OF THE RACEMATE AND INDIVIDUAL ENANTIOMERS OF [C-11] METHYLPHENIDATE FOR STUDYING PRESYNAPTIC DOPAMINERGIC NEURON WITH POSITRON EMISSION TOMOGRAPHY", Journal of labelled compounds & radiopharmaceuticals, 34(10), 1994, pp. 989-997
96. COFFEY LL; REITH MEA
    [H-3] WIN 35,428 BINDING TO THE DOPAMINE UPTAKE CARRIER .1. EFFECT OFTONICITY AND BUFFER COMPOSITION
    Journal of neuroscience methods
    
    L.L. Coffey e M.E.A. Reith, "[H-3] WIN 35,428 BINDING TO THE DOPAMINE UPTAKE CARRIER .1. EFFECT OFTONICITY AND BUFFER COMPOSITION", Journal of neuroscience methods, 51(1), 1994, pp. 23-30
97. REITH MEA; COFFEY LL
    [H-3] WIN 35,428 BINDING TO THE DOPAMINE UPTAKE CARRIER .2. EFFECT OFMEMBRANE FRACTIONATION PROCEDURE AND FREEZING
    Journal of neuroscience methods
    
    M.E.A. Reith e L.L. Coffey, "[H-3] WIN 35,428 BINDING TO THE DOPAMINE UPTAKE CARRIER .2. EFFECT OFMEMBRANE FRACTIONATION PROCEDURE AND FREEZING", Journal of neuroscience methods, 51(1), 1994, pp. 31-38
98. WILSON JM; NOBREGA JN; CORRIGALL WA; COEN KM; SHANNAK K; KISH SJ
    AMYGDALA DOPAMINE LEVELS ARE MARKEDLY ELEVATED AFTER SELF-ADMINISTRATION BUT NOT PASSIVE-ADMINISTRATION OF COCAINE
    Brain research
    
    J.M. Wilson et al., "AMYGDALA DOPAMINE LEVELS ARE MARKEDLY ELEVATED AFTER SELF-ADMINISTRATION BUT NOT PASSIVE-ADMINISTRATION OF COCAINE", Brain research, 668(1-2), 1994, pp. 39-45
99. WONG DF; YUNG B; DANNALS RF; SHAYA EK; RAVERT HT; CHEN CA; CHAN B; FOLIO T; SCHEFFEL U; RICAURTE GA; NEUMEYER JL; WAGNER HN; KUHAR MJ
    IN-VIVO IMAGING OF BABOON AND HUMAN DOPAMINE TRANSPORTERS BY POSITRONEMISSION TOMOGRAPHY USING [C-11] WIN-35,428
    Synapse
    
    D.F. Wong et al., "IN-VIVO IMAGING OF BABOON AND HUMAN DOPAMINE TRANSPORTERS BY POSITRONEMISSION TOMOGRAPHY USING [C-11] WIN-35,428", Synapse, 15(2), 1993, pp. 130-142
100. REITH MEA; COFFEY LL
     CATIONIC AND ANIONIC REQUIREMENTS FOR THE BINDING OF TA-CARBOMETHOXY-3-BETA-(4-FLUOROPHENYL)[3H]TROPANE TO THE DOPAMINE UPTAKE CARRIER
     Journal of neurochemistry
     
     M.E.A. Reith e L.L. Coffey, "CATIONIC AND ANIONIC REQUIREMENTS FOR THE BINDING OF TA-CARBOMETHOXY-3-BETA-(4-FLUOROPHENYL)[3H]TROPANE TO THE DOPAMINE UPTAKE CARRIER", Journal of neurochemistry, 61(1), 1993, pp. 167-177